What is the recommended antiplatelet therapy for patients with STEMI receiving fibrinolytic therapy?
The recommended antiplatelet therapy for patients with STEMI receiving fibrinolytic therapy is aspirin 81- to 325-mg daily maintenance dose (indefinite). For patients aged 75 years and above, a 300 mg loading dose of clopidogrel is recommended, followed by 75 mg daily for at least 14 days and up to 1 year in the absence of bleeding. For patients aged less than 75 years, a loading dose of clopidogrel is not recommended and 75 mg daily should be given for at least 14 days and up to 1 year in the absence of bleeding.